CG Oncology, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.About CGON
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
CEOArthur Kuan
CEOArthur Kuan
Employees113
Employees113
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2010
Founded2010
Employees113
Employees113
CGON Key Statistics
Market cap2.05B
Market cap2.05B
Price-Earnings ratio-15.95
Price-Earnings ratio-15.95
Dividend yield—
Dividend yield—
Average volume453.10K
Average volume453.10K
High today$27.10
High today$27.10
Low today$26.25
Low today$26.25
Open price$26.70
Open price$26.70
Volume366.53K
Volume366.53K
52 Week high$40.47
52 Week high$40.47
52 Week low$14.80
52 Week low$14.80
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CGON. This list is generated using Robinhood data, and it’s not a recommendation.